bat spit drug firm go market german firm whose main product derive saliva vampire bat look raise euros stock market firm paion say hop sell million share third firm euros share main drug desmoteplase base protein bat saliva protein stop blood clotting help bat drink victim could also use help stroke sufferer company share go sale later week schedule start trade frankfurt stock exchange february final price top range company could value much euro money raise spend largely develop company drug since desmoteplase already license one manufacturer forest laboratory